China Aoxing Pharmaceutical Company Announces Successful Completion Of Phase II Clinical Study Of Novel Menstrual Pain Drug
China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) (“China Aoxing”), a pharmaceutical company specializing in research, development, manufacturing and distribution of narcotic and pain-management products, today announced that it completed Phase II clinical study for oral TJSL capsules, a novel investigational drug to treat primary dysmenorrhea (“PD”) , or menstrual pain, in adult women…
Related Posts
Tags: aoxing, china, clinical, company, completion, drug, menstrual, novel, pain, pharmaceutical, phase, study, successful
This entry was posted on Wednesday, January 6th, 2010 at 4:01 pm and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.



